Stem cells — masters of their fates – Nature.com
Nature.com |
Stem cells — masters of their fates
Nature.com Human glioblastomas (GBMs) are thought to harbour a subpopulation of glioblastoma stem cells (GSCs) that govern tumour initiation, maintenance and recurrence after therapy. Although homogeneous GSC populations can produce progenitors with diverse … |
Proactive Investors UK |
WideCells Group to develop stem cells education platform
Proactive Investors UK Stem cell storage and insurance specialist WideCells Group PLC (LON:WDC) is to develop a software platform that both educates and keeps medical professionals and parents up to date on new treatments and developments. WideCells chief executive João … |
Engadget |
CRISPR gene-editing could result in more successful birth rates
Engadget Gene-edited human embryos are offering new insights into the earliest stages of development, and could reduce the risk of miscarriage at the outset of pregnancy. In a new study, researchers from the UK’s Francis Crick Institute used CRISPR Cas9 to … CRISPR gene-editing technology could lower risk of miscarriagesDigital Trends |
The Detroit News |
Cancer immunotherapy is next hottest thing
The Detroit News San Diego — Dennis Lyon was a genetic train wreck. Cancer was ravaging his liver, lungs, bones and brain, and tests showed so many tumor mutations that drugs targeting one or two wouldn’t do much good. It seemed like very bad news, yet his doctors … |
|
Radiation-immunotherapy combination can slow tumor growth for some patients with metastatic late-stage cancer
Markets Insider SAN DIEGO, Sept. 24, 2017/PRNewswire-USNewswire/ — A new study involving patients with stage IV cancer finds that treatment with radiation therapy and immunotherapy can halt the growth of tumors by stimulating the body’s immune system to attack the … Immune response prognostic for prostate cancer survival, recurrence and response to radiation therapyPR Newswire (press release) |
|
Radiation-immunotherapy combination can slow tumor growth for some patients with metastatic late-stage cancer
Markets Insider SAN DIEGO, Sept. 24, 2017/PRNewswire-USNewswire/ — A new study involving patients with stage IV cancer finds that treatment with radiation therapy and immunotherapy can halt the growth of tumors by stimulating the body’s immune system to attack the … Immune response prognostic for prostate cancer survival, recurrence and response to radiation therapyPR Newswire (press release) |